These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 16962735)

  • 1. An LNA-based loss-of-function assay for micro-RNAs.
    Naguibneva I; Ameyar-Zazoua M; Nonne N; Polesskaya A; Ait-Si-Ali S; Groisman R; Souidi M; Pritchard LL; Harel-Bellan A
    Biomed Pharmacother; 2006 Nov; 60(9):633-8. PubMed ID: 16962735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of microRNA with antisense oligonucleotides.
    Esau CC
    Methods; 2008 Jan; 44(1):55-60. PubMed ID: 18158133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of microRNAs for therapeutics.
    Stenvang J; Lindow M; Kauppinen S
    Biochem Soc Trans; 2008 Dec; 36(Pt 6):1197-200. PubMed ID: 19021524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LNA-mediated microRNA silencing in non-human primates.
    Elmén J; Lindow M; Schütz S; Lawrence M; Petri A; Obad S; Lindholm M; Hedtjärn M; Hansen HF; Berger U; Gullans S; Kearney P; Sarnow P; Straarup EM; Kauppinen S
    Nature; 2008 Apr; 452(7189):896-9. PubMed ID: 18368051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation.
    Ji R; Cheng Y; Yue J; Yang J; Liu X; Chen H; Dean DB; Zhang C
    Circ Res; 2007 Jun; 100(11):1579-88. PubMed ID: 17478730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The utility of LNA in microRNA-based cancer diagnostics and therapeutics.
    Stenvang J; Silahtaroglu AN; Lindow M; Elmen J; Kauppinen S
    Semin Cancer Biol; 2008 Apr; 18(2):89-102. PubMed ID: 18295505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the in vitro and in vivo properties of four locked nucleic acid nucleotides incorporated into an anti-H-Ras antisense oligonucleotide.
    Fluiter K; Frieden M; Vreijling J; Rosenbohm C; De Wissel MB; Christensen SM; Koch T; Ørum H; Baas F
    Chembiochem; 2005 Jun; 6(6):1104-9. PubMed ID: 15861430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LNA-modified oligonucleotides mediate specific inhibition of microRNA function.
    Ørom UA; Kauppinen S; Lund AH
    Gene; 2006 May; 372():137-41. PubMed ID: 16503100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LNA-antisense rivals siRNA for gene silencing.
    Jepsen JS; Wengel J
    Curr Opin Drug Discov Devel; 2004 Mar; 7(2):188-94. PubMed ID: 15603252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ detection of miRNAs in animal embryos using LNA-modified oligonucleotide probes.
    Kloosterman WP; Wienholds E; de Bruijn E; Kauppinen S; Plasterk RH
    Nat Methods; 2006 Jan; 3(1):27-9. PubMed ID: 16369549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagomirzymes: oligonucleotide enzymes that specifically silence microRNA function.
    Jadhav VM; Scaria V; Maiti S
    Angew Chem Int Ed Engl; 2009; 48(14):2557-60. PubMed ID: 19229913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single-molecule method for the quantitation of microRNA gene expression.
    Neely LA; Patel S; Garver J; Gallo M; Hackett M; McLaughlin S; Nadel M; Harris J; Gullans S; Rooke J
    Nat Methods; 2006 Jan; 3(1):41-6. PubMed ID: 16369552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miChip: an array-based method for microRNA expression profiling using locked nucleic acid capture probes.
    Castoldi M; Schmidt S; Benes V; Hentze MW; Muckenthaler MU
    Nat Protoc; 2008; 3(2):321-9. PubMed ID: 18274534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitive and specific detection of microRNAs by northern blot analysis using LNA-modified oligonucleotide probes.
    Válóczi A; Hornyik C; Varga N; Burgyán J; Kauppinen S; Havelda Z
    Nucleic Acids Res; 2004 Dec; 32(22):e175. PubMed ID: 15598818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potential for microRNAs.
    Esau CC; Monia BP
    Adv Drug Deliv Rev; 2007 Mar; 59(2-3):101-14. PubMed ID: 17462786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical modification and design of anti-miRNA oligonucleotides.
    Lennox KA; Behlke MA
    Gene Ther; 2011 Dec; 18(12):1111-20. PubMed ID: 21753793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Locked nucleic acid-based in situ detection of microRNAs in mouse tissue sections.
    Obernosterer G; Martinez J; Alenius M
    Nat Protoc; 2007; 2(6):1508-14. PubMed ID: 17571058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies to determine the biological function of microRNAs.
    Krützfeldt J; Poy MN; Stoffel M
    Nat Genet; 2006 Jun; 38 Suppl():S14-9. PubMed ID: 16736018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miChip: a microarray platform for expression profiling of microRNAs based on locked nucleic acid (LNA) oligonucleotide capture probes.
    Castoldi M; Benes V; Hentze MW; Muckenthaler MU
    Methods; 2007 Oct; 43(2):146-52. PubMed ID: 17889802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of microRNAs by Northern blot analyses using LNA probes.
    Várallyay E; Burgyán J; Havelda Z
    Methods; 2007 Oct; 43(2):140-5. PubMed ID: 17889801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.